C4 Therapeutics, Inc. Common Stock (CCCC)

Typically moves ±6.38% on earnings

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-10-16 APPROXIMATE

C4 Therapeutics, Inc. Common Stock (CCCC) has reported earnings 22 times since May 13, 2021. The stock moves an average of ±6.38% the day after reporting, closing higher 68.2% of the time. Its largest post-earnings gain was +31.12% (Aug 07, 2025) and its largest decline was -13.91% (Nov 01, 2023). The next earnings report is predicted for 2026-10-16 (approximate).

Earnings reactions

How CCCC moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±6.38%

Positive %

68.2%

Negative %

31.8%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 11, 2026	☀ PRE	+6.78%	open_in_new
May 12, 2026	☀ PRE	+0.16%	open_in_new
Feb 26, 2026	☀ PRE	+0.18%	open_in_new
Nov 06, 2025	☀ PRE	+0.42%	open_in_new
Aug 07, 2025	☀ PRE	+31.12%	open_in_new
May 07, 2025	☀ PRE	+6.79%	open_in_new
Feb 27, 2025	☀ PRE	-1.52%	open_in_new
Oct 31, 2024	☀ PRE	-3.79%	open_in_new
Aug 01, 2024	☀ PRE	-0.52%	open_in_new
May 08, 2024	☀ PRE	-5.15%	open_in_new
Feb 22, 2024	☀ PRE	+21.49%	open_in_new
Nov 01, 2023	☀ PRE	-13.91%	open_in_new
Aug 08, 2023	☀ PRE	+0.14%	open_in_new
May 04, 2023	☀ PRE	+3.19%	open_in_new
Feb 23, 2023	☀ PRE	+2.03%	open_in_new
Nov 03, 2022	☀ PRE	+1.96%	open_in_new
Aug 04, 2022	☀ PRE	+7.04%	open_in_new
May 05, 2022	☀ PRE	-3.93%	open_in_new
Feb 24, 2022	☀ PRE	+13.74%	open_in_new
Nov 10, 2021	☽ POST	-4.11%	open_in_new
Aug 11, 2021	☽ POST	+10.47%	open_in_new
May 13, 2021	☽ POST	+1.92%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±6.38%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 19 →

Funds holding

$152745919

Total value held

Buying

15 added · 4 reduced

Morgan Stanley

$41410468 -2.26%

Blackrock, Inc.

$36877672 +285.48%

Jpmorgan Chase & Co

$20651295 +47.30%

Goldman Sachs Group Inc

$16489728 +47.90%

Bank Of America Corp /De/

$12405197 +12.59%

SEC Filing Types

description SCHEDULE 13G/A

5 chevron_right

description 8-K

4 chevron_right

description SCHEDULE 13G

3 chevron_right

description 10-Q

1 chevron_right

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
144	20260814	open_in_new SEC.gov
144	20260814	open_in_new SEC.gov
SCHEDULE 13G/A	20260814	open_in_new SEC.gov
SCHEDULE 13G/A	20260814	open_in_new SEC.gov
SCHEDULE 13G/A	20260814	open_in_new SEC.gov
144	20260813	open_in_new SEC.gov
144	20260812	open_in_new SEC.gov
SCHEDULE 13G/A	20260812	open_in_new SEC.gov
10-Q	20260811	open_in_new SEC.gov
8-K	20260811	open_in_new SEC.gov

Frequently asked about CCCC earnings

When does C4 Therapeutics, Inc. Common Stock report earnings next? expand_more

C4 Therapeutics, Inc. Common Stock (CCCC)'s next earnings date is approximate for 2026-10-16. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does CCCC stock move after earnings? expand_more

Over 22 reports, CCCC has moved an average of ±6.38% the session after earnings, closing higher 68.2% of the time.

What was CCCC's biggest post-earnings move? expand_more

CCCC's largest post-earnings gain on record was +31.12% on Aug 07, 2025, and its largest decline was -13.91% on Nov 01, 2023.

Where can I find C4 Therapeutics, Inc. Common Stock's SEC filings? expand_more

All of C4 Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.